Cargando…
The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions
SIMPLE SUMMARY: The Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) is a recently developed tool to identify four distinct molecular subgroups of endometrial cancer. Patients identified as Polymerase Epsilon exonuclease domain mutated (POLE EDM) or p53-mutated have significantly...
Autores principales: | Alexa, Matthias, Hasenburg, Annette, Battista, Marco Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005218/ https://www.ncbi.nlm.nih.gov/pubmed/33806979 http://dx.doi.org/10.3390/cancers13061478 |
Ejemplares similares
-
The role of TCGA molecular classification in clear cell endometrial carcinoma
por: Tang, Xinyue, et al.
Publicado: (2023) -
Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2021) -
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives
por: Arciuolo, Damiano, et al.
Publicado: (2022) -
Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
por: Mustea, Alexander, et al.
Publicado: (2023) -
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
por: León-Castillo, Alicia, et al.
Publicado: (2020)